Novavax COVID-19 Vaccine Effective, but Has Little Effect Against South African Variant

Novavax, a little-known company supported by the United States federal government's Operation Warp Speed, announced that its COVID-19 vaccine proffered robust protection against the novel coronavirus. However, it also discovered that its vaccine is less effective against the fast becoming prevalent variant first detected in South Africa.